Malignant B cells skew the balance of regulatory T cells and T H17 cells in B-cell non-Hodgkin's lymphoma

Cancer Research

Volumn 69, Issue 13, 2009, Pages 5522-5530

  Yang, Zhi Zhang ^a   Novak, Anne J ^a   Ziesmer, Steven C ^a   Witzig, Thomas E ^a   Ansell, Stephen M ^a  

^a Mayo Clinic   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD27 ANTIGEN; CD28 ANTIGEN; CD70 ANTIGEN; CD86 ANTIGEN; CYTOKINE ANTIBODY; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; TRANSCRIPTION FACTOR FOXP3;

ANTIGEN ANTIBODY REACTION; ARTICLE; B CELL LYMPHOMA; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL ACTIVITY; CELL MATURATION; COCULTURE; CONTROLLED STUDY; CPG ISLAND; DOWN REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MICROENVIRONMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; SIGNAL TRANSDUCTION; TH17 CELL; TUMOR BIOPSY; UPREGULATION;

B-LYMPHOCYTES; BIOPSY; CD4-POSITIVE T-LYMPHOCYTES; CYTOKINES; FLOW CYTOMETRY; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; INTERLEUKIN-17; INTERLEUKIN-2; INTERLEUKIN-23; LYMPHOMA, B-CELL; LYMPHOMA, NON-HODGKIN; T-LYMPHOCYTES, REGULATORY; TRANSFORMING GROWTH FACTOR BETA;

EID: 67650446560     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-09-0266     Document Type: Article

References (48)

1. + effector T-cells develop via a lineage distinct from the T helper type 1and 2 lineages. Nat Immunol 2005;6:1123-32.
2. Park H, Li Z, Yang XO, et al. A distinct lineage of CD4 T-cells regulates tissue inflammation by producing interleukin 17. Nat Immunol 2005;6:1133-41.
3. Bettelli E, Carrier Y, Gao W, et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T-cells. Nature 2006;441:235-8.
4. + regulatory T-cells for immunologic self-tolerance and negative control of immune responses. Ann Rev Immunol 2004;22:531-62.
5. + regulatory T-cells by TGF-β induction of transcription factor Foxp3. J Exp Med 2003;198:1875-86.
6. +CD25- T-cells through Foxp3 induction and down-regulation of Smad7. J Immunol 2004;172:5149-53.
7. Acosta-Rodriguez EV, Napolitani G, Lanzavecchia A, Sallusto F. Interleukins 1β and 6 but not transforming growth factor-β are essential for the differentiation of interleukin 17-producing human T helper cells. Nat Immunol 2007;8:942-9.
8. Singh SP, Zhang HH, Foley JF, Hedrick MN, Farber JM. Human T-cells that are able to produce IL-17 express the chemokine receptor CCR6. J Immunol 2008;180:214-21.
9. + effector memory T-cells. J Immunol 2008;180:7948-57.
10. + T-cells in B-cell non-Hodgkin lymphoma. Blood 2006;107:3639-46.
11. Yang ZZ, Novak AJ, Ziesmer SC, Witzig TE, Ansell SM. Attenuation of CD8(+) T-cell function by CD4(+)CD25(+) regulatory T-cells in B-cell non-Hodgkin's lymphoma. Cancer Res 2006;66:10145-52.
12. +CD25 T-cells. Blood 2007;110:2537-44.
13. + regulatory T-cell function. Science (New York, NY) 2005;309:1380-4.
14. A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project. N Engl J Med 1993;329:987-94.
15. Siddiqui M, Ristow K, Markovic SN, et al. Absolute lymphocyte count predicts overall survival in follicular lymphomas. Br J Haematol 2006;134:596-601.
16. Kryczek I, Wei S, Zou L, et al. Cutting edge: Th17 and regulatory T-cell dynamics and the regulation by IL-2 in the tumor microenvironment. J Immunol 2007;178:6730-3.
17. + T-cell immune response to large B-cell non-Hodgkin's lymphoma predicts patient outcome. J Clin Oncol 2001;19:720-6.
18. Acosta-Rodriguez EV, Rivino L, Geginat J, et al. Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells. Nat Immunol 2007;8:639-46.
19. + regulatory T-cells. J Immunol 2008;180:122-9.
20. Annunziato F, Cosmi L, Santarlasci V, et al. Phenotypic and functional features of human Th17 cells. J Exp Med 2007;204:1849-61.
21. + regulatory T-cells. Front Biosci 2008;13:1440-6.
22. Laurence A, Tato CM, Davidson TS, et al. Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation. Immunity 2007;26:371-81.
23. + T-cell-mediated suppression by dendritic cells. Science (New York, NY) 2003;299:1033-6.
24. + regulatory T-cells by antigen-processing dendritic cells. J Exp Med 2003;198:235-47.
25. + regulatory cell activation and function by dendritic cells. Int Immunol 2004;16:1769-80.
26. Nurieva R, Yang XO, Martinez G, et al. Essential autocrine regulation by IL-21 in the generation of inflammatory T-cells. Nature 2007;448:480-3.
27. Steiner GE, Newman ME, Paikl D, et al. Expression and function of pro-inflammatory interleukin IL-17 and IL-17 receptor in normal, benign hyperplastic, and malignant prostate. Prostate 2003;56:171-82.
28. Nam JS, Terabe M, Kang MJ, et al. Transforming growth factor β subverts the immune system into directly promoting tumor growth through interleukin-17. Cancer Res 2008;68:3915-23.
29. Muranski P, Boni A, Antony PA, et al. Tumor-specific Th17-polarized cells eradicate large established melanoma. Blood 2008;112:362-73.
30. Kato T, Furumoto H, Ogura T, et al. Expression of IL-17 mRNA in ovarian cancer. Biochem Biophys Res Commun 2001;282:735-8.
31. Maggio E, van den Berg A, Diepstra A, Kluiver J, Visser L, Poppema S. Chemokines, cytokines and their receptors in Hodgkin's lymphoma cell lines and tissues. Ann Oncol 2002;13 Suppl 1:52-6.
32. Wrobel T, Mazur G, Jazwiec B, Kuliczkowski K. Interleukin-17 in acute myeloid leukemia. J Cell Mol Med 2003;7:472-4.
33. Ciree A, Michel L, Camilleri-Broet S, et al. Expression and activity of IL-17 in cutaneous T-cell lymphomas (mycosis fungoides and Sezary syndrome). Int J Cancer 2004;112:113-20.
34. Wagsater D, Lofgren S, Hugander A, Dimberg J. Expression of interleukin-17 in human colorectal cancer. Anticancer Res 2006;26:4213-6.
35. Le Gouvello S, Bastuji-Garin S, Aloulou N, et al. High prevalence of Foxp3 and IL17 in MMR-proficient colorectal carcinomas. Gut 2008;57:772-9.
36. Chavey C, Bibeau F, Gourgou-Bourgade S, et al. Oestrogen receptor negative breast cancers exhibit high cytokine content. Breast Cancer Res 2007;9:R15.
37. Chen Z, Tato CM, Muul L, Laurence A, O'Shea JJ. Distinct regulation of interleukin-17 in human T helper lymphocytes. Arth Rheum 2007;56:2936-46.
38. Wilson NJ, Boniface K, Chan JR, et al. Development, cytokine profile and function of human interleukin 17-producing helper T-cells. Nat Immunol 2007;8:950-7.
39. + IL-17-producing T-cells in ovarian cancer. Proc Natl Acad Sci U S A 2008;105:15505-10.
40. + T-cell precursor. J Exp Med 2008;205:1903-16.
41. pos regulatory T-cells differentiate into IL-17-producing cells. Blood 2008;112:2340-52.
42. + regulatory T-cells in vivo requires B7 costimulation, but not the thymus. J Exp Med 2005;201:127-37.
43. Amadi-Obi A, Yu CR, Liu X, et al. TH17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27/STAT1. Nat Med 2007;13:711-8.
44. Fantini MC, Rizzo A, Fina D, et al. IL-21 regulates experimental colitis by modulating the balance between Treg and Th17 cells. Eur J Immunol 2007;37:3155-63.
45. Mucida D, Park Y, Kim G, et al. Reciprocal TH17 and regulatory T-cell differentiation mediated by retinoic acid. Science (New York, NY) 2007;317:256-60.
46. + T regulatory cells. Int Immunopharmacol 2007;7:1819-24.
47. Cheng X, Yu X, Ding YJ, et al. The Th17/Treg imbalance in patients with acute coronary syndrome. Clin Immunol (Orlando, FL) 2008;127:89-97.
48. Nistala K, Moncrieffe H, Newton KR, Varsani H, Hunter P, Wedderburn LR. Interleukin-17-producing T-cells are enriched in the joints of children with arthritis, but have a reciprocal relationship to regulatory T-cell numbers. Arth Rheum 2008;58:875-87.